Scientific Reports · 2019 · 47 citations · 46 references
Life SciencesImmunologyNeuroscienceInflammationInnate ImmunityRheumatologyInflammatory ArthritisInflammatory Cell ResponsesInflammatory MediatorsInflammatory PathologyNeuroinflammationStrokeAnti-inflammatory TherapeuticsClaudin-5 RegulationInflammatory Blood-brain Barrier InjuryNeuroinflammation In StrokeNeuroinflammatory InjuryRodent Cerebral IschemiaTumor Necrosis Factor Inhibitor TherapyTumor Necrosis Factor Therapy
Rheumatoid Arthritis (RA) is a chronic inflammatory disorder where incidence and severity of myocardial infarction are increased. Data on the incidence and outcome of stroke are conflicting. Thus, we investigated outcome after Ischemia/Reperfusion (I/R) brain injury in a mouse model of RA and assessed for the role of the tumour necrosis factor-α (TNF-α) inhibitor Infliximab herein. We used a TNF-α reliant mouse model of RA. RA and wildtype (WT) animals were treated with vehicle (RA/WT) or Infliximab (RA Infliximab) for 4 weeks, before undergoing I/R brain injury. RA-animals displayed larger strokes and poorer neurological performance. Immunohistochemistry on brain sections revealed increased numbers of resident and peripheral innate immune cells (microglia and macrophages); increased Blood-Brain-Barrier (BBB)-disruption; decreased levels of the tight junction proteins (TJPs) claudin-5 and occludin; increased expression of matrix-metalloproteinases (MMP)-3 and -9 and enhanced lipid peroxidation. Treatment with Infliximab corrected these alterations. We show that RA associates to worse stroke-outcome via exacerbated BBB degradation by decrease of the TJPs claudin-5 and occludin. We identified MMPs-3 and -9 and increased oxidative stress as potential mediators thereof. Increased numbers of resident and peripheral innate immune cells (microglia and macrophages) may in turn contribute to all these effects. Infliximab-treatment restored the phenotype of RA-mice to baseline. Our data provide evidence clearly linking RA to adverse stroke-outcome in mice and indicate an approved TNF-α inhibitor as a potential strategy to reduce stroke-burden in this setting.
46
Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld et al. · The Lancet · 1999 · 2.4K citations
A Semiautomated Method for Measuring Brain Infarct Volume
Raymond A. Swanson, Matthew T. Morton, George Tsao-Wu et al. · Journal of Cerebral Blood Flow & Metabolism · 1990 · 1.7K citations
Medicine, Neurology, Neuroscience +16
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Jeanne Keffer, Lesley Probert, Haris Cazlaris et al. · The EMBO Journal · 1991 · 1.7K citations · Full text
Life Sciences, Genetics, Immunology +14